These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16362629)

  • 21. Longitudinal changes of CSF biomarkers in Alzheimer's disease.
    Seppälä TT; Koivisto AM; Hartikainen P; Helisalmi S; Soininen H; Herukka SK
    J Alzheimers Dis; 2011; 25(4):583-94. PubMed ID: 21460434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor levels in Alzheimer's disease.
    O'Bryant SE; Hobson V; Hall JR; Waring SC; Chan W; Massman P; Lacritz L; Cullum CM; Diaz-Arrastia R;
    J Alzheimers Dis; 2009; 17(2):337-41. PubMed ID: 19363274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum brain-derived neurotrophic factor levels as a predictor for Alzheimer disease progression.
    Tsai MJ; Lin YS; Chen CY; Lee WJ; Fuh JL
    J Chin Med Assoc; 2023 Nov; 86(11):960-965. PubMed ID: 37713318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Du Y; Wu HT; Qin XY; Cao C; Liu Y; Cao ZZ; Cheng Y
    J Mol Neurosci; 2018 Jul; 65(3):289-300. PubMed ID: 29956088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.
    Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ
    Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease.
    Woolley JD; Strobl EV; Shelly WB; Karydas AM; Robin Ketelle RN; Wolkowitz OM; Miller BL; Rankin KP
    Curr Alzheimer Res; 2012 Sep; 9(7):815-21. PubMed ID: 21605064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methyltransferase 3, a target of microRNA-29c, contributes to neuronal proliferation by regulating the expression of brain-derived neurotrophic factor.
    Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
    Mol Med Rep; 2015 Jul; 12(1):1435-42. PubMed ID: 25815896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease.
    Liguori C; Stefani A; Sancesario G; Sancesario GM; Marciani MG; Pierantozzi M
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):655-9. PubMed ID: 25121572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.
    Chatterjee M; Del Campo M; Morrema THJ; de Waal M; van der Flier WM; Hoozemans JJM; Teunissen CE
    Alzheimers Res Ther; 2018 Jun; 10(1):52. PubMed ID: 29859129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.
    Counts SE; He B; Prout JG; Michalski B; Farotti L; Fahnestock M; Mufson EJ
    Curr Alzheimer Res; 2016; 13(7):800-8. PubMed ID: 26825093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.
    Konukoglu D; Andican G; Fırtına S; Erkol G; Kurt A
    Acta Neurol Belg; 2012 Sep; 112(3):255-60. PubMed ID: 22740022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
    J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.
    Leyhe T; Eschweiler GW; Stransky E; Gasser T; Annas P; Basun H; Laske C
    J Alzheimers Dis; 2009; 16(3):649-56. PubMed ID: 19276559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
    Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S
    JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.